Group One Trading, L.P. Prothena Corp Public LTD CO Transaction History

Group One Trading, L.P.

  • $3.01 Billion
  • Q2 2024

A detailed history of Group One Trading, L.P. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Group One Trading, L.P. holds 6,233 shares of PRTA stock, worth $109,015. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,233
Previous 2,296 171.47%
Holding current value
$109,015
Previous $56,000 128.57%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$19.54 - $26.15 $76,928 - $102,952
3,937 Added 171.47%
6,233 $128,000
Q1 2024

May 10, 2024
SELL
$24.75 - $40.66 $622,710 - $1.02 Million
-25,160 Reduced 91.64%
2,296 $56,000
Q4 2023

Feb 14, 2024
BUY
$32.31 - $52.32 $887,103 - $1.44 Million
27,456 New
27,456 $997,000
Q3 2022

Nov 09, 2022
BUY
$25.16 - $60.63 $95,935 - $231,182
3,813 New
3,813 $231,000
Q2 2022

Aug 11, 2022
SELL
$22.73 - $39.98 $23,389 - $41,139
-1,029 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$30.27 - $49.22 $95,622 - $155,485
-3,159 Reduced 75.43%
1,029 $38,000
Q4 2021

Feb 11, 2022
BUY
$42.11 - $73.26 $94,789 - $164,908
2,251 Added 116.21%
4,188 $207,000
Q3 2021

Nov 12, 2021
BUY
$48.2 - $78.89 $93,363 - $152,809
1,937 New
1,937 $138,000
Q2 2021

Aug 10, 2021
SELL
$21.63 - $57.65 $163,306 - $435,257
-7,550 Closed
0 $0
Q1 2021

May 12, 2021
SELL
$11.0 - $28.24 $53,856 - $138,263
-4,896 Reduced 39.34%
7,550 $190,000
Q4 2020

Feb 10, 2021
BUY
$10.12 - $13.94 $22,375 - $30,821
2,211 Added 21.6%
12,446 $149,000
Q3 2020

Nov 12, 2020
BUY
$9.93 - $13.47 $16,781 - $22,764
1,690 Added 19.78%
10,235 $102,000
Q2 2020

Aug 13, 2020
SELL
$9.56 - $12.51 $98,630 - $129,065
-10,317 Reduced 54.7%
8,545 $89,000
Q1 2020

May 13, 2020
SELL
$7.54 - $15.77 $65,567 - $137,135
-8,696 Reduced 31.56%
18,862 $202,000
Q4 2019

Feb 10, 2020
BUY
$7.48 - $17.01 $159,877 - $363,571
21,374 Added 345.63%
27,558 $436,000
Q3 2019

Nov 12, 2019
SELL
$6.89 - $10.45 $48,939 - $74,226
-7,103 Reduced 53.46%
6,184 $48,000
Q2 2019

Aug 09, 2019
BUY
$8.85 - $12.49 $66,906 - $94,424
7,560 Added 132.01%
13,287 $140,000
Q1 2019

May 13, 2019
SELL
$10.32 - $14.49 $337,020 - $473,199
-32,657 Reduced 85.08%
5,727 $69,000
Q4 2018

Feb 06, 2019
BUY
$8.73 - $13.74 $16,176 - $25,460
1,853 Added 5.07%
38,384 $395,000
Q3 2018

Nov 08, 2018
SELL
$12.7 - $15.79 $148,551 - $184,695
-11,697 Reduced 24.25%
36,531 $478,000
Q2 2018

Aug 14, 2018
BUY
$10.99 - $44.21 $341,448 - $1.37 Million
31,069 Added 181.07%
48,228 $703,000
Q1 2018

May 11, 2018
BUY
$27.95 - $45.04 $387,722 - $624,794
13,872 Added 422.03%
17,159 $630,000
Q4 2017

Feb 09, 2018
BUY
$35.44 - $63.76 $116,491 - $209,579
3,287
3,287 $123,000

Others Institutions Holding PRTA

# of Institutions
179
Shares Held
42.8M
Call Options Held
77.7K
Put Options Held
92.7K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $821M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email